Jessica M. Karmasek Jun. 17, 2013, 10:11pm

WASHINGTON (Legal Newsline) — The U.S. Supreme Court on Thursday ruled mostly against a Utah-based molecular diagnostic company in its attempt to patent a pair of genes linked to breast and ovarian cancer.

In its unanimous opinion, the nation’s high court wrote that defendant Myriad Genetics Inc. “did not create anything.”

“To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention,” Justice Clarence Thomas wrote in the court’s 18-page ruling.

Read the rest of the story on Legal Newsline ...

Want to get notified whenever we write about U.S. Supreme Court ?
Next time we write about U.S. Supreme Court, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

U.S. Supreme Court
1 First St NE
Washington, DC 20543

More News